Bigtincan (BTH) Equity Raising Presentation summary
Event summary combining transcript, slides, and related documents.
Equity Raising Presentation summary
13 Jun, 2025Executive summary and business overview
Bigtincan is a global sales enablement SaaS provider with over 2,000 deployments and 100+ Fortune 500 customers, operating across six verticals and four continents.
GenieAI, a suite of generative AI products, drove over $3 million in AI-influenced deals in Q3 FY24, positioning AI as a core growth driver.
The company extended its $15 million loan facility with Regal Funds Management and received a non-binding, indicative offer from Vector Capital at $0.25 per share.
Tim Ebbeck, with significant enterprise software experience, joined the Board of Directors.
FY24 outlook includes revenue of $120m+, EBITDA of $10m+, adjusted EBITDA of $15m+, and free cash flow of $5m+ in 2H FY24.
Equity raising details
Underwritten 1-for-3 accelerated non-renounceable entitlement offer of 205.4 million shares at $0.10 per share to raise $20.5 million.
Offer price represents a 23.1% discount to TERP and a 28.6% discount to the last traded price on 5 June 2024.
New shares will rank equally with existing shares.
Institutional offer conducted via bookbuild on 11 June 2024; retail offer opens 18 June and closes 2 July 2024.
Henslow Pty Ltd and Canaccord Genuity (Australia) Limited are joint lead managers and underwriters.
Use of proceeds and funding allocation
$5m allocated to core AI technology investments, including AuthoringAI and GenieAI.
$4m for data infrastructure to support GenieAI deployment in the USA, EMEA, and Australia.
$4.5m for market awareness, development, and sales/marketing resources focused on GenieAI, especially in the USA and Europe.
$3m for working capital and $1m for transaction costs.
Latest events from Bigtincan
- Record EBITDA, AI innovation, and Vector's offer highlighted pivotal shareholder decisions.BTH
AGM 20243 Feb 2026 - Record EBITDA and AI-driven growth set the stage for further gains in FY 2025.BTH
H2 202423 Jan 2026 - Schemes of arrangement received near-unanimous proxy support, pending poll validation.BTH
Scheme Meeting 202526 Dec 2025 - Directors were re-elected without contest, and poll results will be announced on the ASX.BTH
EGM 202522 Dec 2025 - $54m goodwill impairment drives $64m loss as Vector Capital acquisition advances.BTH
H1 20255 Jun 2025